Connect with us

HealthTech

Chinese biotech firm Changchun, US-based Yarrow sign $1.4b deal

HealthTech

VeCura ReSculpt Launched by Actress Alya Manasa & Praba Reddy, in Chennai, Redefining Science-Led Non-Surgical Body Sculpting in South India

HealthTech

Dr. Jagdish Sakhiya Launches Anti Acne Kit for Oily and Acne Prone Skin

HealthTech

Health Insurance for Young Professionals: Why Starting Early Saves Money

HealthTech

Implant Dentist Dr Agravat Launches Advanced Dental Implant & Oral Wellness Program to Boost Dental Tourism in Gujarat

HealthTech

Dr. A. K. Dwivedi’s Evidence-Based Work on Aplastic Anemia Gains National Recognition

HealthTech

PharmEasy Health Report 2025: How India Cared for Its Health

HealthTech

Medical Breakthrough: How Robotic Surgery helped achieve Kidney Preservation for Kidney Cancer Patient

HealthTech

Aansh IVF Chandrapur First in Central India to Deploy Garbha.ai with 94 Percent Accuracy Rate

HealthTech

Dr. Arpit Chopra Jain’s distinguished treatment methodology echoes at Oxford University!

AI HealthTech

India Announces First Agentic AI–Powered Multi-Specialty Hospital Pilot

HealthTech

A 31-year-old who lived on a chair… until his spine finally said, ‘Enough’

HealthTech

Psychotherapist Namrata Jain Sounds the Alarm Bells for India’s Silent but Escalating Self-Harm Epidemic

HealthTech

Advanced Treatment for Fistula and Pilonidal Sinus Now Accessible for Palakkad Patients

HealthTech

Leading the Future of Cardiac Care: Dr. Brajmohan Singh’s Journey in Advanced Heart Surgery

HealthTech

Chinese biotech firm Changchun, US-based Yarrow sign $1.4b deal

Published

4 weeks ago

on

[ad_1]

Biopharma
Health Care
Investment

Chinese biopharmaceutical company Changchun High-Tech Industry Group has entered a licensing agreement worth up to $1.4 billion with US-based Yarrow Bioscience for an innovative…

[ad_2]

Source link

Related Topics:
Continue Reading